Erik Stroes

31PUBLICATIONS
150CO-AUTHORS
Respiratory diseasesMolecular targetsCardiology (incl. cardiovascular diseases)Medical biochemistry - lipidsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 20, 2026
Multi-marker inflammatory risk assessment after acute coronary syndrome.

|Mar 30, 2026
Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

|Nov 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.

Nicholas A Marston, Brian A Bergmark, Veronica J Alexander

|Mar 05, 2025
Challenges in achieving LDL cholesterol targets and novel approaches to lipid lowering.

Waqas A Malick, Daein Choi, Anne Langsted

|Feb 06, 2025
The role of systemic inflammation in remnant cholesterol-associated cardiovascular risk: insights from the EPIC-Norfolk study.

Jordan M Kraaijenhof, Marije J Kerkvliet, Nick S Nurmohamed

|Oct 30, 2024
Impact of cumulative LDL cholesterol and other risk factors on coronary artery disease prevalence in patients with familial hypercholesterolaemia.

Shirin Ibrahim, G Kees Hovingh, Barbara A Hutten

Pageof 6

Frequent Collaborators

8 joint publications

Nick S Nurmohamed

6 joint publications

Jordan M Kraaijenhof

6 joint publications

Laurens F Reeskamp

6 joint publications

Jeffrey Kroon